Active substanceSodium chlorideSodium chloride
Similar drugsTo uncover
  • Aqua-Rhinosol
    spray nazal. 
    Firm VIPS-MED, LLC     Russia
  • AquaMaster®
    spray nazal. 
    EVALAR, CJSC     Russia
  • Nazol® Aqua
    spray nazal. 
    BAYER, AO     Russia
  • Sodium chloride
    solution for injections 
    ELLARA, LTD.     Russia
  • Sodium chloride
    solution d / infusion 
  • Sodium chloride
    solution for injections 
    FARMENT FIRM, LLC     Russia
  • Sodium chloride
    solution d / infusion 
    RESERV-M, LLC     Russia
  • Sodium chloride
    solution d / infusion 
    Baxter S.L.     Spain
  • Sodium chloride
    solution in / in d / infusion 
  • Sodium chloride
    solution in / in d / infusion 
    GEMATEK, LLC     Russia
  • Sodium chloride
    solution d / infusion 
  • Sodium chloride
    solution in / in d / infusion 
  • Sodium chloride
    solution d / infusion 
    ESKOM NPK, OAO     Russia
  • Sodium chloride
    solution d / infusion 
    ATOLL, LLC     Russia
  • Sodium chloride
    solution for injections 
  • Sodium chloride
    solution w / m in / in PC 
  • Sodium chloride
    solution for injections 
    DALHIMFARM, OJSC     Russia
  • Sodium chloride
    solution d / infusion 
  • Sodium chloride
    solution d / infusion 
  • Sodium chloride
    solution w / m in / in PC 
  • Sodium chloride
    solution d / infusion 
  • Sodium chloride
    solution d / infusion 
  • Sodium chloride
    solution d / infusion 
    ABOLMED, LLC     Russia
  • Sodium chloride
    solution for injections 
    ESKOM NPK, OAO     Russia
  • Sodium chloride
    solution d / infusion 
  • Sodium chloride
    solution d / infusion 
    KRASFARMA, JSC     Russia
  • Sodium chloride
    solution d / infusion 
    AKAFARM, LLC     Russia
  • Sodium chloride
    solution d / infusion 
  • Sodium chloride
    solution d / infusion 
    FARMLEND JV, LLC     Republic of Belarus
  • Sodium chloride
    solution d / infusion 
    ALTAYVITAMINS, CJSC     Russia
  • Sodium chloride
    solution for injections 
    BIOSINTEZ, PAO     Russia
  • Sodium chloride
    solution for injections 
  • Sodium chloride
    solution for injections 
    SYNTHESIS, OJSC     Russia
  • Sodium chloride
    solution d / infusion 
  • Sodium chloride
    solution d / infusion 
    RESTER, CJSC     Russia
  • Sodium chloride
    solution d / infusion 
    AVEKSIMA, JSC     Russia
  • Sodium chloride
    solution w / m in / in PC 
  • Sodium chloride
    solution d / infusion 
    SAKHAMEDPROM, SUE     Russia
  • Sodium chloride
    solution for injections 
    Mapichem AG     Switzerland
  • Sodium chloride
    solution d / infusion 
    Kelun-Kazfarm, TOO     The Republic of Kazakhstan
  • Sodium chloride B. Brown
    solution for injections 
  • Sodium chloride Brown
    solution d / infusion 
  • Sodium chloride boufouc
    solution for injections 
    UPDATE OF PFC, CJSC     Russia
  • Sodium Chloride-Vial
    solution d / infusion 
    VIAL, LLC     Russia
  • Risosin
    spray nazal. 
    SYNTHESIS, OJSC     Russia
  • Physiodosis
    solution locally 
  • Dosage form: & nbspsolution for infusions
    Composition:

    100 ml of the preparation contain:

    active substance: sodium chloride 0.9 g

    adjuvant: water for injection up to 100 ml.

    Theoretical osmolarity: 308 mOsmol / l.

    Description:

    A clear, colorless solution.

    Pharmacotherapeutic group:Rehydrating agent
    ATX: & nbsp

    B.05.C.B.01   Sodium chloride

    B.05.X.A.03   Sodium chloride

    Pharmacodynamics:

    Sodium chloride has a detoxifying and rehydrating effect.Replenishes sodium deficiency in various pathological conditions of the body. 0.9% solution of sodium chloride is isotonic with human blood plasma, so it is quickly removed from the vascular bed, only temporarily increasing the volume of fluid circulating in the vessels.

    Pharmacokinetics:Quickly excreted by the kidneys unchanged.
    Indications:

    Plasmonisotonic substitution of a liquid, gypsumbad weatherRheumatic alkalosis, hyponatremia with dehydration, intoxication.

    Contraindications:

    Hypernatremia, hyperchloremia, hypokalemia, extracellular hyperhydration, circulatory disorders threatening edema of the brain and lungs, cerebral edema, pulmonary edema, decompensated heart failure, concomitant high-dose corticosteroid therapy, chronic renal failure and conditions that can cause sodium retention, hypervolemia and edema (central and peripheral), such as: primary aldosteronism and secondary aldosteronism, caused, for example, by arterial hypertension throat, congestive heart failure, liver disease (including cirrhosis) and kidneys (including stenosis of the renal arteries and nephrosclerosis),pre-eclampsia; contraindications to the drugs added to the solution.

    Carefully:

    Chronic heart failure, acidosis, arterial hypertension, peripheral edema, toxicosis of pregnant women.

    Pregnancy and lactation:

    The drug can be used during pregnancy and during breastfeeding. Data on the use of the drug during pregnancy and during breastfeeding is not enough.

    Dosing and Administration:

    Intravenously. Before the introduction, the preparation is heated to 36 ° C - 38 ° C.

    Doses, speed and duration of application are selected individually depending on the indication for use, age, body weight, the patient's condition and concomitant therapy, as well as on the effectiveness of treatment in terms of general symptoms and laboratory indicators.

    For adults: an average of 1000 ml / day, with large losses of fluid and intoxications (toxic dyspepsia, cholera), it is possible to administer up to 3000 ml / day. The rate of intravenous injection is 540 ml / h (180 drops / min), if necessary, the rate of administration is increased.

    For children: with shock dehydration (without determining laboratory parameters) 20-30 mg / kg / day are administered.In the future, the dosage regimen is adjusted depending on the laboratory parameters.

    Side effects:

    On the part of the circulatory system: acidosis, hyperhydration, hypokalemia.

    From the immune system: hypersensitivity reactions or infusion reactions, including arterial hypotension, pyrexia, tremor, chills, urticaria, rash, itching.

    General disorders and disorders at the site of administration: reactions at the injection site, such as erythema at the injection site, hemorrhage / hematoma at the injection site, burning sensation, urticaria at the injection site.

    When using the drug as a base solution for other drugs, the likelihood of unwanted reactions is determined by the properties of these drugs. In this case, if unwanted reactions appear, you should suspend the solution, assess the patient's condition, take adequate measures and save the remaining solution for analysis, if necessary.

    Overdose:

    Overdosing can lead to chloride acidosis, hyperhydration, increase the excretion of potassium from the body. When combined with other drugs, complaints with excessive administration are most often associated with the properties of added drugs.

    Overdose Symptoms: vomiting, diarrhea, abdominal cramps, thirst, reduced salivation and lacrimation, sweating, fever, tachycardia, increased blood pressure, renal failure, peripheral edema, pulmonary edema, respiratory arrest, headache, dizziness, restlessness, irritability, weakness , muscle cramps and muscle stiffness, generalized convulsions, coma.

    Treatment: symptomatic. When symptoms of an overdose occur, the drug should be discontinued.

    Interaction:

    Compatible with colloid hemodynamic blood substitutes (mutual enhancement of the effect).

    When mixed with other drugs, you need to visually check for compatibility.

    Special instructions:

    The solution can be used only if it is transparent, without visible inclusions, and its packaging is not broken.

    With prolonged administration of large doses of the drug, it is necessary to monitor the acid-base state and the concentration of electrolytes in blood plasma and urine.

    If there is significant dehydration when intravenous injection is not possible, the drug is administered subcutaneously or rectally.

    Effect on the ability to drive transp. cf. and fur:

    The drug has no effect on the ability to control mechanisms and the car.

    Form release / dosage:

    Solution for infusion 0.9%

    Packaging:

    For 250 or 500 ml in a bottle of low-density polyethylene, closed with a lid of polypropylene. Each label is labeled self-adhesive and placed in a bag of polypropylene BOPP film.

    24 bottles of 250 ml together with an equal number of instructions for use are placed in a box of corrugated cardboard (for hospitals).

    25 bottles of 500 ml together with an equal number of instructions for use are placed in a box of corrugated cardboard (for hospitals).

    Storage conditions:

    Store at a temperature not exceeding 30 ° C.

    Keep out of the reach of children.

    Shelf life:

    3 years.

    Do not use after the expiration date.

    Terms of leave from pharmacies:For hospitals
    Registration number:LP-002677
    Date of registration:24.10.2014 / 08.08.2016
    Expiration Date:24.10.2019
    The owner of the registration certificate:Akulayf Helskea Pvt. Ltd.Akulayf Helskea Pvt. Ltd. India
    Manufacturer: & nbsp
    Representation: & nbspCompany AlkemiCompany Alkemi
    Information update date: & nbsp15.06.2018
    Illustrated instructions
      Instructions
      Up